All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
FDA Seeks Accelerated Drug Approval, DSHEA, Cosmetics Legislative Reforms
By Pete Evich, AAHP Government Relations As part of the President's FY 2023 Budget proposal, FDA has called upon Congress to take up legislation that...
The Legal Status of the HPUS as an Official Compendium
By Al Lorman, AAHP Counsel Pharmacopoeias have been around for thousands of years. Historically, they provided the medical community with critical information necessary to make...
Recent HPCUS Meetings and Updates
By Eric Foxman, Pharm. (Ret.), AAHP Secretary The Homeopathic Pharmacopoeia Convention of the United States held its annual meeting in the latter half of April....
The Homeopathic Pharmacopoeia Convention of the United States Continues to Play a Vital Role
By Mark Land, AAHP President The first edition of the Homeopathic Pharmacopoeia of the United States (HPUS) was first published in 1897 - 125 years...
Case Study: Updating & Revising HPUS Monographs
By Eric Foxman, Pharm. (Ret.), AAHP Secretary What is the process through which the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) revises monographs? What...
Be ’Recall Ready’: FDA Wants to Help You Fulfill Your Regulatory Requirements
By Eric Foxman, AAHP Secretary Does your company market or distribute an FDA-regulated product? If so, then FDA has a document for you. FDA wants...
Homeopathic Community Responds to BJM Article on Reporting Bias
By Mark Land, AAHP President You may have seen recent reports about a new study claiming that most homeopathic research is of poor quality,...
